These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 26482227)

  • 1. Tumor size, stage and grade alterations of urinary peptidome in RCC.
    Chinello C; Cazzaniga M; De Sio G; Smith AJ; Grasso A; Rocco B; Signorini S; Grasso M; Bosari S; Zoppis I; Mauri G; Magni F
    J Transl Med; 2015 Oct; 13():332. PubMed ID: 26482227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic analysis reveals differentially secreted proteins in the urine from patients with clear cell renal cell carcinoma.
    Sandim V; Pereira Dde A; Kalume DE; Oliveira-Carvalho AL; Ornellas AA; Soares MR; Alves G; Zingali RB
    Urol Oncol; 2016 Jan; 34(1):5.e11-25. PubMed ID: 26420021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histology-guided proteomic analysis to investigate the molecular profiles of clear cell Renal Cell Carcinoma grades.
    Stella M; Chinello C; Cazzaniga A; Smith A; Galli M; Piga I; Grasso A; Grasso M; Del Puppo M; Varallo M; Bovo G; Magni F
    J Proteomics; 2019 Jan; 191():38-47. PubMed ID: 29698802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations of the serum peptidome in renal cell carcinoma discriminating benign and malignant kidney tumors.
    Gianazza E; Chinello C; Mainini V; Cazzaniga M; Squeo V; Albo G; Signorini S; Di Pierro SS; Ferrero S; Nicolardi S; van der Burgt YE; Deelder AM; Magni F
    J Proteomics; 2012 Dec; 76 Spec No.():125-40. PubMed ID: 22868251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Searching for prognostic biomarkers for small renal masses in the urinary proteome.
    Di Meo A; Batruch I; Brown MD; Yang C; Finelli A; Jewett MA; Diamandis EP; Yousef GM
    Int J Cancer; 2020 Apr; 146(8):2315-2325. PubMed ID: 31465112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic evaluation of urine from renal cell carcinoma using SELDI-TOF-MS and tree analysis pattern.
    Wu DL; Zhang WH; Wang WJ; Jing SB; Xu YM
    Technol Cancer Res Treat; 2008 Jun; 7(3):155-60. PubMed ID: 18473487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urine screening by Seldi-Tof, followed by biomarker identification, in a Brazilian cohort of patients with renal cell carcinoma (RCC).
    Alves G; Pereira DA; Sandim V; Ornellas AA; Escher N; Melle C; von Eggeling F
    Int Braz J Urol; 2013; 39(2):228-39. PubMed ID: 23683669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary RKIP/p-RKIP is a potential diagnostic and prognostic marker of clear cell renal cell carcinoma.
    Papale M; Vocino G; Lucarelli G; Rutigliano M; Gigante M; Rocchetti MT; Pesce F; Sanguedolce F; Bufo P; Battaglia M; Stallone G; Grandaliano G; Carrieri G; Gesualdo L; Ranieri E
    Oncotarget; 2017 Jun; 8(25):40412-40424. PubMed ID: 28418894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic urinary miRNAs for the assessment of small renal masses.
    Di Meo A; Brown MD; Finelli A; Jewett MAS; Diamandis EP; Yousef GM
    Clin Biochem; 2020 Jan; 75():15-22. PubMed ID: 31672647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GC-MS metabolomics-based approach for the identification of a potential VOC-biomarker panel in the urine of renal cell carcinoma patients.
    Monteiro M; Moreira N; Pinto J; Pires-Luís AS; Henrique R; Jerónimo C; Bastos ML; Gil AM; Carvalho M; Guedes de Pinho P
    J Cell Mol Med; 2017 Sep; 21(9):2092-2105. PubMed ID: 28378454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of potential serum proteomic biomarkers for clear cell renal cell carcinoma.
    Yang J; Yang J; Gao Y; Zhao L; Liu L; Qin Y; Wang X; Song T; Huang C
    PLoS One; 2014; 9(11):e111364. PubMed ID: 25368985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Prognostic Biomarkers in the Urinary Peptidome of the Small Renal Mass.
    Di Meo A; Batruch I; Brown MD; Yang C; Finelli A; Jewett MAS; Diamandis EP; Yousef GM
    Am J Pathol; 2019 Dec; 189(12):2366-2376. PubMed ID: 31761032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic profiling of urinary proteins in renal cancer by surface enhanced laser desorption ionization and neural-network analysis: identification of key issues affecting potential clinical utility.
    Rogers MA; Clarke P; Noble J; Munro NP; Paul A; Selby PJ; Banks RE
    Cancer Res; 2003 Oct; 63(20):6971-83. PubMed ID: 14583499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery and validation of urinary biomarkers for detection of renal cell carcinoma.
    Frantzi M; Metzger J; Banks RE; Husi H; Klein J; Dakna M; Mullen W; Cartledge JJ; Schanstra JP; Brand K; Kuczyk MA; Mischak H; Vlahou A; Theodorescu D; Merseburger AS
    J Proteomics; 2014 Feb; 98():44-58. PubMed ID: 24374379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary nuclear matrix protein 22 for diagnosis of renal cell carcinoma.
    Kaya K; Ayan S; Gokce G; Kilicarslan H; Yildiz E; Gultekin EY
    Scand J Urol Nephrol; 2005; 39(1):25-9. PubMed ID: 15764267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accurate quantification of urinary metabolites for predictive models manifest clinicopathology of renal cell carcinoma.
    Sato T; Kawasaki Y; Maekawa M; Takasaki S; Shimada S; Morozumi K; Sato M; Kawamorita N; Yamashita S; Mitsuzuka K; Mano N; Ito A
    Cancer Sci; 2020 Jul; 111(7):2570-2578. PubMed ID: 32350988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary signatures of Renal Cell Carcinoma investigated by peptidomic approaches.
    Chinello C; Cazzaniga M; De Sio G; Smith AJ; Gianazza E; Grasso A; Rocco F; Signorini S; Grasso M; Bosari S; Zoppis I; Dakna M; van der Burgt YE; Mauri G; Magni F
    PLoS One; 2014; 9(9):e106684. PubMed ID: 25202906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Protein Profiling in a Cohort of Egyptian Population with Renal Cell Carcinoma and Benign Kidney Neoplasms.
    Kandil NS; Ghazala RA; El Sharkawy RM; Youssif TA; Noha Abouseda N
    Asian Pac J Cancer Prev; 2019 Jul; 20(7):2145-2152. PubMed ID: 31350978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary Application of WCX Magnetic Bead-Based Matrix-Assisted Laser Desorption Ionization Time-of-Flight Mass Spectrometry in Analyzing the Urine of Renal Clear Cell Carcinoma.
    Dong DX; Ji ZG; Li HZ; Yan WG; Zhang YS
    Chin Med Sci J; 2017 Dec; 32(4):248-252. PubMed ID: 29301600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of SELDI-TOF-MS to identify serum biomarkers for renal cell carcinoma.
    Xu G; Xiang CQ; Lu Y; Kang XN; Liao P; Ding Q; Zhang YF
    Cancer Lett; 2009 Sep; 282(2):205-13. PubMed ID: 19362769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.